Boxer Capital Management, LLC: 13F holdings
CIK 20182992026Q2
| Positions | 63 |
|---|
| Reported value | $1.3bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 63 (+9 vs prior quarter) |
|---|
| Reported value | $1.3bn (+74.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| TNGX TANGO THERAPEUTICS INC | 10,876,219 | $340.0m | 25.6% |
| RVMD REVOLUTION MEDICINES INC | 500,000 | $93.6m | 7.1% |
| ABVX ABIVAX SA | 605,000 | $80.6m | 6.1% |
| UNIQURE NV | 1,503,300 | $69.2m | 5.2% |
| KOD KODIAK SCIENCES INC | 1,477,600 | $57.6m | 4.3% |
| KYMR KYMERA THERAPEUTICS INC | 429,100 | $49.2m | 3.7% |
| DFTX DEFINIUM THERAPEUTICS INC | 998,500 | $47.0m | 3.5% |
| REPL REPLIMUNE GROUP INC | 3,983,000 | $44.1m | 3.3% |
| CELC CELCUITY INC | 416,530 | $43.6m | 3.3% |
| Q32 BIO INC | 3,149,310 | $40.1m | 3.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2018299")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples